Texas Biomed News

Mymetics’ HIV vaccine candidate confirms promise in preclinical study with Texas Biomed | 04.11.2016

Mymetics Corporation (OTCQB: MYMX) announced today that its innovative HIV vaccine candidate has shown to generate significant protection in groups of twelve female monkeys against repeated AIDS virus exposures during part of the preclinical study at Texas Biomedical Research Institute. | Read the full story

Discoveries Eblast - Forum Gala Update | 03.15.2016

March Discoveries e-newsletter shares news on the Texas Biomedical Forum Gala in May! | Read the full story

Collaborative Study Shows Promising Safety Results for Anti-Aging Drug | 02.09.2016

A recent collaborative study published in the November issue of the journal Aging showed minimal metabolic side effects after continuous, long-term treatment with encapsulated rapamycin in a marmoset (monkey) model. Study results have led to a new grant with the Barshop Institute to study the drug's effectiveness in the marmoset model. | Read the full story

     

Biosafety Level 4 Laboratory

Learn More


Genomics Computing Resources

Learn More


Community Engagement

ScienceWriters2016 Call for Speakers

 Learn More

Planning
Animal Research Saves lives
Support Texas Biomedical